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Procedure TnT < 0.1 0.1-0.2 >0.2
Abdom. Aortic Aneur. 39 (66%) 13 (22%) 7{12%)
Other vascular 160 (79%) 20(10%) 23(11%)
Thoracic 75 (64%) 30 (26%) 12(10%)
Abdominal 99 (89%) 8( 7%) 4( 4%)
Orthopedic 304 (92%) 16( 5%) 12( 4%)
Other 180 (87%) 16( 8%) 10( 5%)
8.1*
4.6
Total
4.3*
1.9
Mortality
Cardiac
38*
27
Lp(a) is a Predictor of Coronary Artery Disease in
Pre-menopausal but not in Post-menopausal
Women
LIPIDS - CLINICAL AND BASIC
Low Total Cholesterol is Associated with Higher
Mortality in Patients with Coronary Heart Disease
Serum Cholesterol and Lipoprotein
Concentrations in Black Bears
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Low T-C (n ~ 554)
Others (n ~ 13199)
ABSTRACfS 25A
Conclusions: Although data from RHC adds statistically significant infor-
mation to standard clinical and LHC measures, the magnitude is small (12%
of total prognostic information available) and probably does not justify RHC
as routine preoperative investigation.
Elevated serum cholesterol (CHOL) concentration and low HDL concentra-
tion are linked to the development of atherosclerotic heart disease (AHD).
High CHOL levels have been reported in both denning and non-denning
bears, yet coronary artery atherosclerosis has not been observed. Lipopro-
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*p < 0.001
Multivariate logistic analysis adjusting for age, gender, past history, clinical
and laboratory findings, yielded a relative risk for total mortality among pts.
with low TC of 1.48 (90% Confidence Interval 1.14-1.93).
Conclusion: In this large group of pts with CAD, low TC was associated
with excess total and cardiac mortality. Longer follow-up and further investi-
gation are necessary to clarify the meaning of this association.
Pts group
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Coronary artery disease (CAD) risk increases in women after menopause.
Although numerous reports suggest that lipid profile worsening after
menopause may be associated with an increase in CAD among women,
there have been few studies that discussed the contribution of Lp(a). To ex-
amine the association between CAD and Lp(a) in pre-menopausal (PR, <55
yo) and post-menopausal (pO, 0::55 yo) women, we evaluated Lp(a) levels
and other risk factor prevalence in 180 female patients 120 to 77 yo) with an-
giographically defined CAD. Six risk factors were assessed: hyper-Lpla)emia
(Hi-Lp(a), Lpla) 0:: 30 mg/dl). hyper-LDLemia (Hi-LDL, LDL 2: 160 mg/dl), hypo-
HDLemia (Lo-HDL, HDL < 35 mg/dl), hypertension, diabetes, and smoking.
Cases were defined as those who had 2: 1 coronary artery with >50% steno-
sis. There were more patients with Hi-Lp(a) (61 %* vs 27%), Hi-LDL (61 %**
vs 5%) and smoking (61 %** vs 9%) in PR cases (n = 18) as compaved with
those in PR controls (n = 22). PO cases (n ~ 93) had more Lo-HDL (15%*
vs 2%), diabetes (33%** vs 13%) and smokers (61 %** vs 9%) than PO con-
trols (n = 47) did. The median Lp(a) of PR cases was higher than that of PR
controls (38.8*,22.7 mg/dl), and they increased with number of diseased ar-
teries. In contrast, there was no difference in the Lp(a) levels between PO
cases and PO controls 121.7,25.2 mg/dl). Logistic regression model also re-
vealed that Hi-Lp(a) was an independent predictor of CAD after controlling
for Hi-LDL, Lo-HDL. hypertension, diabetes and smoking among PR IB =
2.44, SE = 1.20, P < 0.051. but not among PO. Our data suggests that Lp(a)
may be a strong risk factor for CAD in pre-menopausal women, and in post-
menopausal women other risk factors, such as an estrogen deficiency, may
play an important role. (*p < 0.05, **p < 0.01).
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Several studies have shown an association between low total cholesterol
(TC) and increased mortality. Among 13,753 patients (pts) of both genders
with coronary artery disease (CAD) aged 45-70 yrs (mean 61 yrs) screened
for the Bezafibrate Infarction Prevention (BIP) Study, 554 pts (4.0%) had low
TC (:::160 mg/dl) mean (147 ± 12 mg/dl). Age, clinical findings and medical
treatments were similarin ptswith 10wTC and pts with TC > 160 mg/dl (mean
222 ± 36 mg/dl). The former had lower mean HDL-C (32.5 ± 8.6 mg/dl) and
triglyceride levels (119 ± 66 mg/dl) in comparison to pts with TC > 160 mg/dl
(37.9 ± 10.0 mg/dl and 164 ± 93 mg/dl respectively) Three year mortality
rates after screening were as follows for both groups:
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Troponin T and Perioperative Ischemia in
Noncardiac Surgery
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Prognostic Value of Right Heart Catheterization
Hemodynamic Data in Surgically Treated Patients
with Coronary Artery Disease
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To evaluate troponin T (TnT) as a marker for perioperative ischemia, we
prospectively studied 1028 patients (PTS) undergoing major noncardiac
procedures. Clinical data included preoperative examinations, daily clinical
follow-up, and serial electrocardiograms, CK/CK-MB, and TnT levels. Ma-
jor cardiac complications (CaMPS) were classified by reviewers blinded to
TnT data in 29 (3%) of PTS, inclUding acute myocardial infarction (AMII. pul-
monary edema, cardiac arrest, complete heart block, and sustained ventric-
ular tachycardia or fibrillation. AMI was diagnosed using CK-MB criteria in
14 (1.4%) PTS, for whom peak TnT levels were >0.1 mcg~ in 86% and >0.2
mcg/I in 62%. No postoperative clinical complications occurred to the two
PTS with CK-MB criteria for AMI but normal TnT levels. Among the 1014 PTS
without CK-MB criteria for AMI, CaMPS occurred in 5 (0.6%) of 855 PTS
with TnT S 0.1 mcgll versus 10 (6%) of 159 with higher peak TnT levels (p
< 0.0001). This table shows the distribution of peak TnT levels by procedure
type:
We conclude that Tnt correlates with rates of CaMP after major noncar-
diac surgery even among PTS without AMI by CK-MB criteria. In this cohort,
elevated TnT levels were more common with procedures generally associ-
ated with a higher risk of CaMPS. Long term follow-up is needed to de-
termine whether elevated TnT levels in patients without CaMPS were false
positive results or subclinical ischemic events.
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Routine right heart catheterization (RHC) provides limited prognostic infor-
mation in medically treated patients with coronary artery disease. The use
of this procedure in patients undergoing coronary artery bypass grafting has
been more widely advocated. To determine the value of this practice, we
investigated the added prognostic content of hemodynamic data obtained
from 11 RHC variables in 1054 consecutive surgically treated patients (pts)
with significant coronary artery disease (0::75% stenosis) between 8/6/69 and
1/1/80. During this period, RHC was performed routinely on all patients un-
dergoing left heart catheterization (LHC). Follow up was 97% complete. Uni-
variate RHC predictors of survival included pulmonary vascular resistance
(PVR). right atrial mean (RAMI. CO, CI, AV02 difference, RV systolic pressure,
PA systolic, mean and diastolic pressures, and pulmonary capillary wedge
pressure (p < 0.0001 for each).
ng base/mL. No significant differences between ranolazine and placebo were
observed at trough with mean ranolazine plasma levels ranging from 235 to
514 ng base/mL. No clinically meaningful hemodynamic changes or adverse
events occurred with ranolazine compared with placebo. In summary, ra-
nolazine was well tolerated over a wide range of plasma levels. Ranolazine
increased exercise times with no detectable effect on cardiac hemodynam-
ics in patients with chronic stable angina taking other antianginal drugs.
Male
EF (median)
Hx of CHF
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Using a Cox model the independent predictive value of each RHC vari-
able was analyzed when added to a prognostic model derived from clini-
cal and LHC data. RAM (x 2 = 18.5, P < 0.001) and PVR (x 2 = 8.45, P <
0.001) added independent information to the standard clinical and invasive
(left heart) prognostic factors. A significant interaction was found between
PVR and EF Ip = 0.0067) indicating that elevated PVR contained more prog-
nostic information in patients with normal or elevated EF.
